We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+25.53%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.84B
AUM Growth
+$360M
Cap. Flow
-$149M
Cap. Flow %
-5.26%
Top 10 Hldgs %
25.12%
Holding
310
New
37
Increased
50
Reduced
189
Closed
10

Top Buys

Rank Stock Value
1
MEDP icon
Medpace
MEDP
+$24.7M
2
ARNA
Arena Pharmaceuticals Inc
ARNA
+$21.7M
3
FOLD
Amicus Therapeutics
FOLD
+$12.1M
4
PBH icon
Prestige Consumer Healthcare
PBH
+$11.6M
5
LGND icon
Ligand Pharmaceuticals
LGND
+$10.8M

Top Sells

Rank Stock Value
1
IMMU
Immunomedics Inc
IMMU
+$51M
2
ETSY icon
Etsy
ETSY
+$38.3M
3
AIMT
Aimmune Therapeutics
AIMT
+$33.6M
4
BSTC
BioSpecifics Technologies Corp.
BSTC
+$19.5M
5
TTD icon
Trade Desk
TTD
+$12.2M

Sector Composition

Rank Sector Weight
1 Healthcare 26.47%
2 Technology 23.43%
3 Industrials 17.34%
4 Consumer Discretionary 13.01%
5 Communication Services 6.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHRS icon
126
Coherus Oncology
CHRS
$192M
$3.66M 0.13%
210,495
-73,866
-26% -$1.32M
HURN icon
127
Huron Consulting
HURN
$2.42B
$3.66M 0.13%
62,046
+6,374
+11% +$291K
RCM
128
DELISTED
R1 RCM Inc. Common Stock
RCM
$3.62M 0.13%
150,750
-53,157
-26% -$1.06M
MGNI icon
129
Magnite
MGNI
$3.47B
$3.38M 0.12%
110,106
-100,373
-48% -$1.52M
ACA icon
130
Arcosa
ACA
$7.11B
$3.31M 0.12%
60,226
-21,492
-26% -$1.1M
MYRG icon
131
MYR Group
MYRG
$5.14B
$3.28M 0.12%
54,555
-2,161
-4% -$107K
STRL icon
132
Sterling Infrastructure
STRL
$16.2B
$3.27M 0.12%
175,700
-6,984
-4% -$114K
PFPT
133
DELISTED
Proofpoint, Inc.
PFPT
$3.23M 0.11%
+23,647
New +$2.59M
CUB
134
DELISTED
Cubic Corporation
CUB
$3.23M 0.11%
52,005
-33,353
-39% -$2.03M
EW icon
135
Edwards Lifesciences
EW
$53B
$3.19M 0.11%
34,989
-6,501
-16% -$539K
VMC icon
136
Vulcan Materials
VMC
$37B
$3.18M 0.11%
21,425
-3,486
-14% -$497K
NEO icon
137
NeoGenomics
NEO
$2.14B
$3.17M 0.11%
58,818
-2,369
-4% -$107K
FMC icon
138
FMC
FMC
$1.31B
$3.14M 0.11%
27,321
-4,953
-15% -$551K
MTRN icon
139
Materion
MTRN
$5.83B
$3.11M 0.11%
48,857
+7,994
+20% +$460K
CELH icon
140
Celsius Holdings
CELH
$6.89B
$3.08M 0.11%
183,906
-68,106
-27% -$680K
TVTX icon
141
Travere Therapeutics
TVTX
$5.74B
$3.05M 0.11%
+111,864
New +$2.61M
PACK icon
142
Ranpak Holdings
PACK
$446M
$3.01M 0.11%
223,810
-8,368
-4% -$92.1K
PRIM icon
143
Primoris Services
PRIM
$4.35B
$2.99M 0.11%
108,398
-38,232
-26% -$880K
TECH icon
144
Bio-Techne
TECH
$11.2B
$2.98M 0.1%
37,472
-6,232
-14% -$451K
EBIX
145
DELISTED
Ebix Inc
EBIX
$2.84M 0.1%
74,722
-2,709
-3% -$76.2K
ALNT icon
146
Allient
ALNT
$1.92B
$2.83M 0.1%
83,136
-3,459
-4% -$101K
TTC icon
147
Toro Company
TTC
$9.4B
$2.82M 0.1%
29,713
-4,655
-14% -$412K
XYL icon
148
Xylem
XYL
$28.3B
$2.74M 0.1%
26,938
-4,616
-15% -$434K
JOUT icon
149
Johnson Outdoors
JOUT
$501M
$2.73M 0.1%
24,245
-986
-4% -$89.7K
STAA icon
150
STAAR Surgical
STAA
$1.25B
$2.72M 0.1%
34,349
-1,359
-4% -$99.4K
4 5
6
7 8

Similar funds

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM

Rice Hall James & Associates's Q4 2020 Portfolio in Review

As of Q4 2020, Rice Hall James & Associates held 310 positions worth $2.84B, up 15% from $2.48B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Rice Hall James & Associates withdrew a net $149M in Q4 2020, closing 10 positions and reducing 189 holdings. Its most notable exit was Immunomedics Inc, an estimated $51M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in Medpace worth $27.3M.

  • Rice Hall James & Associates's largest Q4 2020 buy was Medpace: 195,984 shares worth $27.3M.
  • Rice Hall James & Associates added most to Prestige Consumer Healthcare in Q4 2020, an estimated $11.6M increase.
  • Rice Hall James & Associates's biggest Q4 2020 reduction was Etsy, cutting an estimated $38.3M.
  • Rice Hall James & Associates fully exited Immunomedics Inc in Q4 2020, selling an estimated $51M.
  • Rice Hall James & Associates's ten largest holdings make up 25% of its $2.84B portfolio in Q4 2020.
  • Rice Hall James & Associates opened 37 new positions and closed 10 in Q4 2020.
  • Rice Hall James & Associates's portfolio value rose 15% quarter-over-quarter to $2.84B.

Based on Rice Hall James & Associates's 13F filing for Q4 2020, filed 16 Feb 2021.